Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era
Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era
复制标题
社论:后基因组时代针对病原体的分子疫苗
DOI:
10.3389/fcimb.2019.00443
复制
发表时间:
2020-01
影响因子:
5.7
通讯作者:
Moreno Alberto
中科院分区:
文献类型:
--
作者:
Alej;ro Onate Angel;Wan Yanmin;Moreno Alberto
The development and implementation of vaccines are one of the greatest Public Health achievements in human history (Centers-for-Disease-Control-and-Prevention, 2011a,b). In the first decade of the twenty-first century, the Expanded Program on Immunizations averts more than 2.5million deaths every year (WHO, 2009). Vaccines not only prevent deaths, disease, and disability but also provide community protection by reducing the spread of the disease within a population (Orenstein and Ahmed, 2017). In the US alone, it has been estimated that the prevention of clinical cases and deaths by vaccination for a single birth cohort represents a net savings of $68.8 billion in total societal costs (Zhou et al., 2014). Although there are vaccines internationally available against 26 infectious diseases, nearly half of all deaths from infectious diseases are caused by pathogens for which no vaccine is available (Piot et al., 2019), including emerging and re-emerging pathogens (Williamson and Westlake, 2019). Interestingly, the majority of these vaccines have been developed empirically with limited information available on the mechanisms involved in protection (Pulendran and Ahmed, 2011). The development of high-throughput technologies and the advances in bioinformatics allow the massive generation and integration of datasets from multiple components of a biological system to understand in-depth physiological or pathological events (Pezeshki et al., 2019). This holistic approach of systems biology, when applied to studies of vaccine-induced immune responses, is known as system vaccinology (Pulendran et al., 2010). This research field will provide tools not only for the rational vaccine design but also for the development of novel adjuvants and vaccine delivery systems (Raeven et al., 2019). In this Frontiers Research Topic, some concepts of modern vaccinology are explored.
登录
查看更多内容
影响因子:
30.5
作者:
Pulendran B;Ahmed R
通讯作者:
Ahmed R
影响因子:
5.4
作者:
A. Mantovani;A. Santoni
通讯作者:
A. Mantovani;A. Santoni
影响因子:
6.4
作者:
Raeven RHM;van Riet E;Meiring HD;Metz B;Kersten GFA
通讯作者:
Kersten GFA
影响因子:
4.6
作者:
E. Williamson;G. Westlake
通讯作者:
E. Williamson;G. Westlake
DOI:
--
发表时间:
2011
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Ten Great;Public Health
通讯作者:
Ten Great;Public Health